InsidersTradesSigma
ゼリア新薬工業株式会社 Stock: price and management transactions · Japan · EDINET (Japan FSA)
Follow the ゼリア新薬工業株式会社 share price and the full insider trade history of the company, a listed equity based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, ゼリア新薬工業株式会社 has recorded 5 insider filings. Market capitalisation: €92.1bn. The latest transaction was reported on 29 July 2024 (Holding update). Among the most active insiders: Mitsubishi UFJ Financial Group Inc.. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,147 of 28,064 companies
72.7
score / 100
Value80
Quality65
FCF yld7.7%
Earn yld9.2%
EV/EBITDA6.9x
ROE8.5%
Gross mgn73%
Net mgn9.5%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 July 2024
Declarations5 total
ShareXTKSEDINET:S100U3FU
100.0% of flowShareXTKSEDINET:S100T8HR
0.0049% mcap61.6% of flowShareXTKSEDINET:S100O7UL
1,532,800 shares0.0031% mcap38.4% of flowShareXTKSEDINET:S100MDSY
5 of 5 declarations
About ゼリア新薬工業株式会社
Zeria Pharmaceutical Co., Ltd. is a Japanese company specializing in the health and pharmaceutical sector. It focuses on the research, development, and marketing of innovative medicines.